GB202112635D0 - Treatment regimen - Google Patents
Treatment regimenInfo
- Publication number
- GB202112635D0 GB202112635D0 GBGB2112635.4A GB202112635A GB202112635D0 GB 202112635 D0 GB202112635 D0 GB 202112635D0 GB 202112635 A GB202112635 A GB 202112635A GB 202112635 D0 GB202112635 D0 GB 202112635D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment regimen
- regimen
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2112635.4A GB202112635D0 (en) | 2021-09-06 | 2021-09-06 | Treatment regimen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2112635.4A GB202112635D0 (en) | 2021-09-06 | 2021-09-06 | Treatment regimen |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202112635D0 true GB202112635D0 (en) | 2021-10-20 |
Family
ID=78076759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2112635.4A Ceased GB202112635D0 (en) | 2021-09-06 | 2021-09-06 | Treatment regimen |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202112635D0 (en) |
-
2021
- 2021-09-06 GB GBGB2112635.4A patent/GB202112635D0/en not_active Ceased
Non-Patent Citations (10)
Title |
---|
BERR CMDI DALMAZI GOSSWALD ARITZEL KBIDLINGMAIER MGEYER LLTREITL MHALLFELDT KRACHINGER WREISCH N: "Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology", J CLIN ENDOCRINOL METAB, vol. 100, 2015, pages 1300 - 1308 |
BORNSTEIN SRALLOLIO BARLT WBARTHEL ADON-WAUCHOPE AHAMMER GDHUSEBYE ESMERKE DPMURAD MHSTRATAKIS CA: "Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline", J CLIN ENDOCRINOL METAB, vol. 101, 2016, pages 364 - 389 |
BROERSEN LHPEREIRA AMJORGENSEN JODEKKERS OM: "Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis", J CLIN ENDOCRINOL METAB, vol. 100, 2015, pages 2171 - 2180 |
BURMESTER GRBUTTGEREIT FBERNASCONI CALVARO-GRACIA JMCASTRO NDOUGADOS MGABAY CVAN LAAR JMNEBESKY JMPETHOE-SCHRAMM A: "Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial", LANCET, vol. 396, 2020, pages 267 - 276, XP086226070, DOI: 10.1016/S0140-6736(20)30636-X |
BUTTGEREIT FDOERING GSCHAEFFLER AWITTE SSIERAKOWSKI SGROMNICA-LHLE EJEKA SKRUEGER KSZECHINSKI JALTEN R: "Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis", ANN RHEUM DIS, vol. 69, 2010, pages 1275 - 1280 |
GRABER ALNEY RLNICHOLSON WEISLAND DPLIDDLE GW: "Natural History of Pituitary-Adrenal Recovery Following Long-Term Suppression with Corticosteroids", J CLIN ENDOCRINOL METAB, vol. 25, 1965, pages 11 - 16 |
JOSEPH RMHUNTER ALRAY DWDIXON WG: "Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review", SEMIN ARTHRITIS RHEUM, vol. 46, 2016, pages 133 - 141, XP029666365, DOI: 10.1016/j.semarthrit.2016.03.001 |
SIMPSON HTOMLINSON JWASS JDEAN JARLT W: "Guidance for the prevention and emergency management of adult patients with adrenal insufficiency", CLIN MED (LOND, vol. 20, 2020, pages 371 - 378 |
WALLACE BIWALLACE DMWALJEE AKCLAUW DJ: "Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking", ANN RHEUM DIS, vol. 78, 2019, pages 1733 - 1734 |
WHITAKER MJDEBONO MHUATAN HMERKE DPARLT WROSS RJ: "An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure", CLIN ENDOCRINOL (OXF, vol. 80, 2014, pages 554 - 561, XP055129260, DOI: 10.1111/cen.12316 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202108224D0 (en) | Treatment | |
GB202116743D0 (en) | Treatment | |
GB202103122D0 (en) | Treatment | |
GB202016058D0 (en) | Therapeautic treatment | |
GB202003722D0 (en) | Treatment | |
GB202002711D0 (en) | Treatment | |
GB202112635D0 (en) | Treatment regimen | |
GB202019215D0 (en) | Treatment regimen | |
GB202017853D0 (en) | Treatment regimen | |
GB202008478D0 (en) | Treatment regimen | |
GB202001514D0 (en) | Treatment regimen | |
GB202212963D0 (en) | Treatment regimen | |
GB202117511D0 (en) | Treatment regimens | |
GB202114373D0 (en) | Treatment | |
GB202109815D0 (en) | Treatment | |
GB202109812D0 (en) | Treatment | |
GB202104666D0 (en) | COVID-19 treatment | |
GB202104416D0 (en) | Treatment reginmens | |
GB202103957D0 (en) | Treatment | |
GB202102488D0 (en) | Treatment | |
GB202102410D0 (en) | Treatment | |
GB202102366D0 (en) | Treatment | |
GB202102373D0 (en) | Treatment | |
GB202102369D0 (en) | Treatment | |
GB202101875D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |